Zydus gets USFDA approval for anti-hypertensive tablets
Indian pharmaceutical major Zydus Cadila has received final nod for its anti-hypertensive drug Olmesartan Medoxomil from USFDA, the company said […]
Say something
Ajanta Pharma denies alert from USFDA
Ajanta Pharma clarified that there is no import alert by US FDA on our facility or any of our products […]
Aurobindo Pharma inks 135-mn deal to buy Portugal’s Generis
Hyderabad-based Indian pharmaceutical major Aurobindo Pharma has signed a 135-million euro deal to buy Generis Farmaceutica SA, a company that […]
Ireena Vittal appointed Cipla’s independent director
Ireena Vittal, a former partner with McKinsey & Co and senior management consultant with over two decades of experience, has […]
Ajanta Pharma launches BP lowering tablets in US
Mumbai-headquartered drug firm, Ajanta Pharma has launched blood pressure lowering tablet in the US market. The medicine has been launched […]
Wockhardt Hospitals: Ensuring Fast & Easy Access to Healthcare Services
Wockhardt Hospitals has been not only adopting latest technologies, but also establishing an environment allowing experimentation and customisation according to […]
Strides Shasun receives USFDA approval for Ranitidine Tablets
Strides Shasun Limited on August 24 announced that it has received approval from the United States Food & Drug […]
-
-
Flipkart Health+ App Launched
06-04-2022
